Edition:
United States

Heron Therapeutics Inc (HRTX.OQ)

HRTX.OQ on NASDAQ Stock Exchange Capital Market

15.95USD
8 Dec 2017
Change (% chg)

$0.50 (+3.24%)
Prev Close
$15.45
Open
$15.55
Day's High
$16.12
Day's Low
$15.55
Volume
202,908
Avg. Vol
155,236
52-wk High
$18.35
52-wk Low
$12.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.85 December 9 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 3 2
(2) OUTPERFORM 7 8 8 7
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.64 1.67 1.73 1.78

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 10 8.58 9.53 7.00 18.82
Quarter Ending Mar-18 4 11.75 14.84 9.00 --
Year Ending Dec-17 10 29.21 30.25 27.00 48.77
Year Ending Dec-18 10 67.37 105.60 42.36 171.19
Earnings (per share)
Quarter Ending Dec-17 10 -0.85 -0.74 -0.96 -0.65
Quarter Ending Mar-18 4 -0.65 -0.50 -0.87 --
Year Ending Dec-17 10 -3.40 -3.31 -3.52 -3.70
Year Ending Dec-18 10 -2.38 -1.52 -3.35 -0.72
LT Growth Rate (%) 2 34.85 47.80 21.90 138.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 8.22 8.57 0.35 4.27
Quarter Ending Jun-17 5.54 8.51 2.97 53.59
Quarter Ending Mar-17 2.59 3.63 1.04 40.37
Quarter Ending Dec-16 1.09 1.28 0.19 17.65
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 8.58 8.58 8.57 8.89 18.82
Quarter Ending Mar-18 11.75 11.85 11.85 11.58 --
Year Ending Dec-17 29.21 29.21 28.89 29.31 48.77
Year Ending Dec-18 67.37 67.66 68.66 69.82 171.19

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 1 0 1
Year Ending Dec-17 0 1 1 1
Year Ending Dec-18 0 1 0 1
Earnings